HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stakeholders Worry Consumer Health Product AERs Will Go To CPSC Database

This article was originally published in The Tan Sheet

Executive Summary

The consumer health care products industry questions whether consumers have been informed about the kind of product safety incidents that should go to the Consumer Product Safety Commission's public reporting database instead of FDA.

You may also be interested in...



CHPA Favors Alternate Plan For CPSC Database Covering OTCs, Supplements

The Consumer Healthcare Products Association says an alternate proposal for implementing the Consumer Product Safety Information Database will ensure information published from consumer complaints is accurate and verifiable.

Package Certification Law Bears Down On Vitamins As Trade Groups Scramble

Vitamin supplement makers are adjusting begrudgingly to a certification requirement affecting packaging for products containing a certain amount of iron

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel